rs45446492
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_000245.4(MET):c.2192G>A(p.Arg731Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000479 in 1,461,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. R731R) has been classified as Likely benign.
Frequency
Consequence
NM_000245.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MET | NM_000245.4 | c.2192G>A | p.Arg731Gln | missense_variant | Exon 9 of 21 | ENST00000397752.8 | NP_000236.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MET | ENST00000397752.8 | c.2192G>A | p.Arg731Gln | missense_variant | Exon 9 of 21 | 1 | NM_000245.4 | ENSP00000380860.3 | ||
MET | ENST00000318493.11 | c.2192G>A | p.Arg731Gln | missense_variant | Exon 9 of 21 | 1 | ENSP00000317272.6 | |||
MET | ENST00000436117.3 | n.2192G>A | non_coding_transcript_exon_variant | Exon 9 of 20 | 1 | ENSP00000410980.2 | ||||
MET | ENST00000422097.2 | c.2192G>A | p.Arg731Gln | missense_variant | Exon 9 of 12 | 3 | ENSP00000398776.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249238Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135218
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461604Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727102
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Renal cell carcinoma Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 731 of the MET protein (p.Arg731Gln). This variant is present in population databases (rs45446492, gnomAD 0.006%). This missense change has been observed in individual(s) with breast cancer (PMID: 35264596). ClinVar contains an entry for this variant (Variation ID: 452678). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MET protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
The R731Q variant in the MET gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The R731Q variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The R731Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position in the IPT/TIG2 domain where amino acids with similar properties to Arginine are tolerated across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret R731Q as a variant of uncertain significance. -
Papillary renal cell carcinoma type 1 Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R731Q variant (also known as c.2192G>A), located in coding exon 8 of the MET gene, results from a G to A substitution at nucleotide position 2192. The arginine at codon 731 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at